Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma

Calcium-dependent adhesion protein CDH18, a potential biomarker for prognosis in uterine corpus endometrial carcinoma

BackgroundUterine corpus endometrial carcinoma (UCEC) is one of the most common cancers in women, yet lacks specific and sensitive tumor markers for diagnosis, as traditional markers like CA125 show limited specificity. This study investigates the clinical significance and prognostic value of CDH18,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoxuan Tang, Shanxing Dang, Jie Qiu, Ruilan Zhou, Jing Ling, Limei Zhang, Xiaopeng Peng, Qingyun Li, Jin Liu, Wei Liao, Qingxiu Mei, Miao Xie, Yehong Sun, Jianmei Huang, Xuelian Du, Wencong Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Molecular Biosciences
Subjects:	uterine corpus endometrial carcinoma CDH18 prognostic biomarkers immune microenvironment calcium-dependent adhesion protein
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2025.1530253/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploratory Analysis of Radiomics and Pathomics in Uterine Corpus Endometrial Carcinoma
by: Valentina Brancato, et al.
Published: (2024-12-01)

Construction of cuproptosis-related genes risk model predicts the prognosis of Uterine Corpus Endometrial Carcinoma
by: Yanfang Huang, et al.
Published: (2025-01-01)

CCDC138 overexpression predicts poor prognosis and highlights ciliopathy-linked mechanisms in uterine corpus endometrial carcinoma
by: Aiping Wang, et al.
Published: (2025-08-01)

A novel mitochondrial-related risk model for predicting prognosis and immune checkpoint blockade therapy response in uterine corpus endometrial carcinoma
by: Ru-Gen Liao, et al.
Published: (2025-01-01)

Lactylation-related risk model for prognostication and therapeutic responsiveness in uterine corpus endometrial carcinoma
by: Yupeng Yin, et al.
Published: (2025-05-01)

MYB Proto-Oncogene Like 2 identified as a biomarker for uterine corpus endometrial carcinoma: evidence from bioinformatics and clinical validation
by: Jiaoyun Lu, et al.
Published: (2025-05-01)

Immunogenic cell death-related genes as prognostic biomarkers and therapeutic insights in uterine corpus endometrial carcinoma: an integrative bioinformatics analysis
by: Tianfei Yi, et al.
Published: (2025-07-01)

Cyclin D2 – a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis
by: Lizhen Wang, et al.
Published: (2025-07-01)

Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
by: Yiming Liu, et al.
Published: (2025-02-01)

Expression and prognostic value of EGF-like domain multiple 6 in uterine corpus endometrial carcinoma and its correlation with immune cell infiltration
by: Qiannan Li, et al.
Published: (2025-07-01)

Celastrol promotes DNA damage and apoptosis in uterine corpus endometrial carcinoma via promotion of KAT2B-mediated RBPJ acetylation and repression of MCM4 transcription
by: Lipeng Pei, et al.
Published: (2025-02-01)

Expression and prognosis of NR3C1 in uterine corpus endometrial carcinoma based on multiple datasets
by: Yahui Shen, et al.
Published: (2025-03-01)

Anti-tumor immune modulation and favorable survival outcomes in uterine corpus endometrial carcinoma: insights from PIK3CA/ARID1A co-mutation analysis
by: Dongmei Han, et al.
Published: (2025-04-01)

Markers of proliferation and angiogenesis in endometrial hyperplastic processes combined with uterine fibroids
by: Yu. Ya. Krut, et al.
Published: (2020-04-01)

Identification of an Immune Cell Infiltration-Related Prognostic Model to Guide Immunotherapy in Endometrial Carcinoma
by: Haijun Zhu, et al.
Published: (2023-10-01)

Mesonephric-like adenocarcinoma of the uterine corpus with focal sarcomatous differentiation: A case report
by: Serika Kanao, et al.
Published: (2025-02-01)

Using Mask Technique and Center Detection for Congenital Dislocation of the Hip (CDH) Diagnosis
by: Nidal AL-Assady, et al.
Published: (2007-07-01)

Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy
by: Chen Fu, et al.
Published: (2025-03-01)

Multiple Pseudo-Placentational Endometrial Hyperplasia (PEH) as a Rare Uterine Disorder in the Bitch
by: Andrzej Łobaczewski, et al.
Published: (2025-02-01)

A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer
by: Peter Jung, et al.
Published: (2024-12-01)

OPTIMIZATION OF THE CHOICE OF ADJUVANT THERAPY IN PATIENTS WITH UTERINE CORPUS CANCER
by: А. L. Chernyshova, et al.
Published: (2016-02-01)

Endometrial hyperplasia and endometrial polyps: clinical and anamnestic characteristics of women
by: E. N. Kravchenko, et al.
Published: (2024-01-01)

ABERRANT METHYLATION OF THE PROMOTER OF APC, CDH13 AND MGMT GENES IN COLORECTAL CANCER PATIENTS
by: O. I. Kit, et al.
Published: (2016-07-01)

Role of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization
by: Yunbo Wu, et al.
Published: (2025-05-01)

Treatment of uterine fibroid: focus on endometrial receptivity. A pilot randomized prospective study
by: Yulia E. Dobrokhotova, et al.
Published: (2024-12-01)

Cloning and Transcriptional Activity Analysis of the Bovine <i>CDH11</i> Gene Promoter: Transcription Factors Sp1 and GR Regulate Bovine <i>CDH11</i> Expression
by: Zhanxin Liu, et al.
Published: (2025-04-01)

Current approaches to the treatment of endometrial hyperplasia in women with uterine leiomyoma
by: Potapov V.A., et al.
Published: (2014-09-01)

Endometrial stromal sarcoma: A review of the literature
by: Geetha Puliyath, et al.
Published: (2012-01-01)

CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress
by: Wenlin Gong, et al.
Published: (2025-08-01)

Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
by: I. V. Kaplieva, et al.
Published: (2024-09-01)

A Prospective Study to Evaluate the Prevalence of Microsatellite Instability in Endometrial Carcinoma by using Immunohistochemistry for Mismatch Repair Proteins as a Surrogate Marker
by: Prithviraj K. Solanki, et al.

CTNNB1 and CDH1 Regulate Trophoblast Cell Adhesion and Junction Formation in Yak Placental Tissue at Different Gestational Stages
by: Bohao Zhang, et al.
Published: (2025-03-01)

Validation of Pipelle endometrial biopsy in patients with abnormal uterine bleeding in Kazakhstani healthcare setting
by: Gulzhanat Aimagambetova, et al.
Published: (2021-06-01)

The diagnostic value of endometrial cytology in diagnosing endometrial pathology
by: Nadezhda Hinkova, et al.
Published: (2025-03-01)

Histopathological findings on endometrial biopsy in a tertiary care center of Nepal: a retrospective cross-sectional study
by: Amar Narayan Shrestha, et al.
Published: (2022-03-01)

Single nucleotide polymorphisms in the CDH18 gene affect growth traits in Hu sheep
by: Tianyi Liu, et al.
Published: (2025-08-01)

Role of the Anaphase-Promoting Complex Activator Cdh1 in the Virulence of <i>Cryptococcus neoformans</i>
by: Qiu-Hong Liao, et al.
Published: (2024-12-01)

The estimated incidence of uterine corpus cancers among permanent residents in mainland China using Bayesian spatial modeling
by: Shuxiu Hao, et al.
Published: (2025-05-01)

Experience in treating uterine proliferative processes in infertile women
by: L. A. Shcherbakova, et al.
Published: (2014-07-01)

Circ_0006646 Promotes the Progression of Osteoarthritis via Upregulating CDH11 Expression in an IGF2BP2‐Dependent Manner
by: Ming‐Yu Hua, et al.
Published: (2025-08-01)